Idarucizumab: The Antidote for Reversal of Dabigatran (Q28085093)

scientific article

Language	Label	Description	Also known as
English	Idarucizumab: The Antidote for Reversal of Dabigatran	scientific article

Statements

instance of

1 reference

Idarucizumab: The Antidote for Reversal of Dabigatran (English)

1 reference

1 reference

1

John W. Eikelboom

1 reference

4

Jeffrey I. Weitz

1 reference

2

Daniel J. Quinlan

1 reference

Joanne van Ryn

3

1 reference

stated in

Crossref

language of work or name

1 reference

22 December 2015

1 reference

1 reference

132

1 reference

stated in

PubMed

issue

25

1 reference

stated in

PubMed

page(s)

2412-22

1 reference

stated in

PubMed

Identifiers

DOI

10.1161/CIRCULATIONAHA.115.019628

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

539003

OpenCitations bibliographic resource ID

539003

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

539003

PubMed publication ID

26700008

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

539003

Idarucizumab: The Antidote for Reversal of Dabigatran (Q28085093)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Idarucizumab: The Antidote for Reversal of Dabigatran (Q28085093)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search